Latest News in the Life Sciences Industry
GlobeNewswire
New Phase 1 Data Show VNA-318 Mechanism of Action Translates to Humans, Supporting Potential to Address Medical Needs of People with Neurodegenerative Diseases
13 Jul 2026
GlobeNewswire
Santhera Expands Biomedica Agreement to Extend AGAMREE® (Vamorolone) Distribution Across Central Asia and the Caucasus
13 Jul 2026
PR Newswire Association LLC.
AbbVie Employees Across Asia Unite Through Week of Possibilities by Serving and Supporting Communities
13 Jul 2026
PR Newswire Association LLC.
MindMaze Therapeutics Supports University of Pittsburgh Study on a Combination Approach to Stroke Recovery, Pairing Spinal Cord Stimulation with High-Dose, High-Intensity Neurotherapy
09 Jul 2026
GlobeNewswire
Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities
08 Jul 2026
GlobeNewswire
Addex Announces Publication of Research Highlighting Therapeutic Potential of mGlu7 Modulation in Regulating Sleep and Wakefulness
08 Jul 2026
PR Newswire Association LLC.
dsm-firmenich awards 2026 Nutrition Research Grant to five projects investigating the role of nutrients and bio-actives in supporting healthy longevity in Asia Pacific
08 Jul 2026
PR Newswire Association LLC.
Wegovy® (semaglutide) label updated in Singapore with higher dose supported by STEP UP evidence
08 Jul 2026
GlobeNewswire
AC Immune to Showcase Neurodegenerative Disease Pipeline with Three Presentations at AAIC® 2026
07 Jul 2026
GlobeNewswire
SPRINT® PNS Publication Highlights Sustained Benefits in Low Back Pain Patients
07 Jul 2026
GlobeNewswire
Roche presents new data in Alzheimer’s disease from across its integrated pharmaceutical and diagnostics portfolio at AAIC
07 Jul 2026
GlobeNewswire
Pharvaris Announces FDA Acceptance of New Drug Application for Deucrictibant IR for On-Demand Treatment of Hereditary Angioedema Attacks
06 Jul 2026
GlobeNewswire
REPRONOVO ANNOUNCES FIRST PARTICIPANT DOSED IN EU PHASE 2 TRIAL OF RPN-002 FOR EMBRYO IMPLANTATION
06 Jul 2026
GlobeNewswire
Novartis agrees to acquire Myricx Bio, advancing next-generation antibody-drug conjugate innovation with a novel NMTi payload, expanding options for cancer patients
06 Jul 2026
Upcoming Events All Events
- October 2026
- Milan: CPHI Milan 2026
- Basel: 26th Annual Biotech in Europe Forum
- Yokohama: BioJapan